Literature DB >> 31742067

A Survival Analysis of Hypopharyngeal Cancer Patients: A Hospital-Cancer registry Based Study.

Manigreeva Krishnatreya1, Amal Chandra Kataki1,2, Jagannath Dev Sharma3,4, Nizara Baishya4, Tashnin Rahman5, Mouchumee Bhattcharyya6, Ashok Kumar Das5, Manoj Kalita7.   

Abstract

To study the survival in patients affected with hypopharyngeal cancer among treatment groups and different stages. Data of hypopharyngeal cancer patients diagnosed from 1st January 2010 to 31st December 2010 was used in the present study. The cases were analyzed for gender, age group distribution, sub-sites at presentation, stage at diagnosis and the type of treatments. Survival from the date of first diagnosis was estimated and hazard ratios were calculated. Survival probability and hazards ratios (HR) were calculated by Kaplan-Meier method and Cox-proportional regression analysis respectively. Censoring of patient who survived longer than 5 years was done. Active follow-up was done for the survival analysis. The study cohort included 217 patients and treatment compliance was observed in 46.9% of cases. The median age at diagnosis was 57 years (range 24-90), 86.2% of cases were locally advanced cases (stage III and IV), pyriform sinus was major sub-site (96%), radiotherapy was main treatment modality alone in 84.8% of cases, median survival was 31 months and 5-year overall survival was 36.9%, and HR for stage IV was 1.9 (P = 0.03, 95% CI - 1.04 to 3.7). In developing setting of North East India, radiotherapy was the main modality of treatment for hypopharyngeal cancer patients, and understanding the clinical parameters and survival of this group of cancers is crucial for its control. © Association of Otolaryngologists of India 2018.

Entities:  

Keywords:  Chemotherapy; Hypopharynx; Radiotherapy; Survival

Year:  2018        PMID: 31742067      PMCID: PMC6848493          DOI: 10.1007/s12070-018-1556-4

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  29 in total

1.  Randomized Clinical Trials and Observational Studies: Is There a Battle?

Authors:  Mariana Chavez-MacGregor; Sharon H Giordano
Journal:  J Clin Oncol       Date:  2016-01-19       Impact factor: 44.544

2.  Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis.

Authors:  Benjamin Lacas; Jean Bourhis; Jens Overgaard; Qiang Zhang; Vincent Grégoire; Matthew Nankivell; Björn Zackrisson; Zbigniew Szutkowski; Rafał Suwiński; Michael Poulsen; Brian O'Sullivan; Renzo Corvò; Sarbani Ghosh Laskar; Carlo Fallai; Hideya Yamazaki; Werner Dobrowsky; Kwan Ho Cho; Beth Beadle; Johannes A Langendijk; Celia Maria Pais Viegas; John Hay; Mohamed Lotayef; Mahesh K B Parmar; Anne Aupérin; Carla van Herpen; Philippe Maingon; Andy M Trotti; Cai Grau; Jean-Pierre Pignon; Pierre Blanchard
Journal:  Lancet Oncol       Date:  2017-07-27       Impact factor: 41.316

3.  Radiotherapy and Concurrent Chemo-Radiotherapy in Locally Advanced Hypopharyngeal Cancers--A Hospital Registry Based Analysis.

Authors:  Jagannath Dev Sharma; Manigreeva Krishnatreya; Ashok Kumar Das; Mouchumee Bhattacharyya; Munlima Hazarika; Amal Chandra Kataki; Nizara Baishya; Pintu Nandy
Journal:  Asian Pac J Cancer Prev       Date:  2015

4.  Comparison of Oncological and Functional Outcomes between Initial Surgical versus Non-Surgical Treatments for Hypopharyngeal Cancer.

Authors:  Jeon Yeob Jang; Eun-Hye Kim; Jungkyu Cho; Jae-Hoon Jung; Dongryul Oh; Yong Chan Ahn; Young-Ik Son; Han-Sin Jeong
Journal:  Ann Surg Oncol       Date:  2016-01-19       Impact factor: 5.344

5.  Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.

Authors:  Neil M Woody; Matthew C Ward; Shlomo A Koyfman; Chandana A Reddy; Jessica Geiger; Nikhil Joshi; Brian Burkey; Joseph Scharpf; Eric Lamarre; Brandon Prendes; David J Adelstein
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-03-18       Impact factor: 7.038

Review 6.  Hypopharyngeal cancer.

Authors:  Nathaniel D Wycliffe; Ryan Shane Grover; Paul D Kim; Alfred Simental
Journal:  Top Magn Reson Imaging       Date:  2007-08

7.  The natural history of patients with squamous cell carcinoma of the hypopharynx.

Authors:  Stephen F Hall; Patti A Groome; Jonathan Irish; Brian O'Sullivan
Journal:  Laryngoscope       Date:  2008-08       Impact factor: 3.325

8.  Squamous cell carcinoma of the hypopharynx: single-institution outcome analysis of a large cohort of patients treated with primary non-surgical approaches.

Authors:  Tejpal Gupta; Supriya Chopra; Jai Prakash Agarwal; Sarbani-Ghosh Laskar; Anil K D'cruz; Shyam K Shrivastava; Ketayun A Dinshaw
Journal:  Acta Oncol       Date:  2009       Impact factor: 4.089

9.  Survival in Head and Neck Cancers - Results of A Multi- Institution Study.

Authors:  Ambakumar Nandakumar; Ambakumar Nandakumar
Journal:  Asian Pac J Cancer Prev       Date:  2016

10.  Chloroquine-enhanced efficacy of cisplatin in the treatment of hypopharyngeal carcinoma in xenograft mice.

Authors:  Xing-guo Zhao; Rui-jie Sun; Xiao-yan Yang; Da-yu Liu; Da-peng Lei; Tong Jin; Xin-liang Pan
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

View more
  1 in total

1.  High Pretreatment LDH Predicts Poor Prognosis in Hypopharyngeal Cancer.

Authors:  Jialing Wu; Kaiyun You; Changlong Chen; Huimin Zhong; Yanhui Jiang; Huaqian Mo; Juanjuan Song; Xingsheng Qiu; Yimin Liu
Journal:  Front Oncol       Date:  2021-03-11       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.